Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 16, 2020 01:00 ET | Source: INNATE PHARMA

Innate Pharma Announces the Appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer

MARSEILLE, France, July 16, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the appointment of Dr....
July 16, 2020 01:00 ET | Source: INNATE PHARMA

Innate Pharma announces the appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical Officer

Pierre Dodion, MD retires as Chief Medical Officer Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the appointment of Dr. Joyson...
July 16, 2020 01:00 ET | Source: INNATE PHARMA

Innate Pharma annonce la nomination de Joyson Karakunnel, MD, MSC, FACP, au poste de Directeur Médical

Pierre Dodion, MD, Directeur Médical, prend sa retraite Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd’hui la...
June 24, 2020 01:00 ET | Source: INNATE PHARMA

U.S. Food and Drug Administration Lifts Partial Clinical Hold on Lacutamab TELLOMAK Trial in Advanced T-Cell Lymphomas

Innate Pharma to re-activate TELLOMAK trial in the US New GMP-certified batch has been successfully manufactured Conference call to be held today on the lacutamab clinical trial program ...
June 24, 2020 01:00 ET | Source: INNATE PHARMA

U.S. Food and Drug Administration lifts partial clinical hold on lacutamab TELLOMAK trial in advanced T-cell lymphomas

Innate Pharma to re-activate TELLOMAK trial in the US New GMP-certified batch has been successfully manufactured Conference call to be held today on the lacutamab clinical trial program Innate...
June 24, 2020 01:00 ET | Source: INNATE PHARMA

L'agence américaine du médicament lève la suspension partielle de l'essai TELLOMAK évaluant lacutamab chez les patients présentant un lymphome T avancé

Réactivation de l’essai TELLOMAK aux Etats-Unis Un nouveau lot de produit clinique certifié Bonnes Pratiques de Fabrication a été fabriqué avec succès Une conférence téléphonique qui fera le point...
May 20, 2020 01:00 ET | Source: INNATE PHARMA

Outcome Of Annual General Meeting Of May 19, 2020

MARSEILLE, France, May 20, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announces the results of the vote of its...
May 20, 2020 01:00 ET | Source: INNATE PHARMA

Outcome of Annual General Meeting of May 19, 2020

Pascale Boissel appointed new member of Innate’s Supervisory Board Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announces the results of...
May 20, 2020 01:00 ET | Source: INNATE PHARMA

Résultats de l'Assemblée Générale Mixte du 19 mai 2020

Nomination de Pascale Boissel au Conseil de Surveillance d’Innate Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce les résultats du...
May 14, 2020 01:00 ET | Source: INNATE PHARMA

Innate Pharma to Present New Efficacy Data For Monalizumab in Combination With Cetuximab in Head And Neck cancer at The ASCO20 Virtual Scientific Progral

Phase II expansion cohort of “IO-pretreated patients” demonstrates 20% overall response rate Data confirm previous preliminary efficacy data seen in this subpopulation Innate Pharma SA (Euronext...